Physician profile
Steven A Fayer
NPI 1669567640
$3,170.35
in general payments reported to CMS, 2019-2025
12 companies · $153 in 2025
The $153 reported for 2025 was more than what 99% of Sports Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $32.19).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,329 · 2020: $297 · 2021: $526 · 2022: $457 · 2023: $259 · 2024: $148 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $591.06 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $552.72 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $548.96 | 2019-2024 | Trintellix |
| Allergan, INC. | $386.54 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $348.55 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $239.53 | 2023-2024 | Quviviq |
| Bausch Health US, LLC | $199.57 | 2019-2022 | |
| Lundbeck LLC | $169.73 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $52.40 | 2019 | |
| Almatica Pharma LLC | $31.40 | 2021-2023 | Loreev Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.00 | 2020 | |
| Adlon Therapeutics L.P. | $24.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Fayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.